BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36617454)

  • 1. Post COVID-19 Guillain-Barre syndrome presents as sensory dominant neuropathy with reversible conduction failure.
    AlTahan AM; AlAnazi MH; AlTahan FA; AlAbandi FA
    Neurosciences (Riyadh); 2023 Jan; 28(1):57-61. PubMed ID: 36617454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible conduction failure is distinct from neurophysiological patterns of recovery in mild demyelinating Guillain-Barré syndrome.
    Kokubun N; Shahrizaila N; Hirata K; Yuki N
    J Neurol Sci; 2013 Mar; 326(1-2):111-4. PubMed ID: 23394975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual sensory variant of Guillain-Barré syndrome.
    Semproni M; Gibson G; Kuyper L; Tam P
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrodiagnosis of reversible conduction failure in Guillain-Barré syndrome.
    Chan YC; Punzalan-Sotelo AM; Kannan TA; Shahrizaila N; Umapathi T; Goh EJH; Fukami Y; Wilder-Smith E; Yuki N
    Muscle Nerve; 2017 Nov; 56(5):919-924. PubMed ID: 28093784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible conduction failure on the deep tendon reflex response recording in early Guillain-Barré syndrome.
    García A; Sedano MJ; Álvarez-Paradelo S; Berciano J
    Clin Neurophysiol Pract; 2018; 3():159-163. PubMed ID: 30560219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finger Drop-Dominant Variant of Guillain-Barre Syndrome in a Patient With COVID-19: A Case Report.
    Kang M; Seok HY
    J Korean Med Sci; 2022 May; 37(20):e160. PubMed ID: 35607739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two sets of nerve conduction studies may suffice in reaching a reliable electrodiagnosis in Guillain-Barré syndrome.
    Shahrizaila N; Goh KJ; Abdullah S; Kuppusamy R; Yuki N
    Clin Neurophysiol; 2013 Jul; 124(7):1456-9. PubMed ID: 23395599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes.
    Uncini A; Manzoli C; Notturno F; Capasso M
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1157-63. PubMed ID: 20870864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of sensory nerve conduction studies in the diagnosis of Guillain-Barré syndrome.
    Freiha J; Zoghaib R; Makhoul K; Maalouf N; Riachi N; Chalah MA; Ayache SS; Ahdab R
    Clin Neurophysiol; 2021 May; 132(5):1157-1162. PubMed ID: 33780722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible Conduction Failure in Chronic Immune-Mediated Sensorimotor and Autonomic Polyneuropathy.
    Shouman K; Dhamne M; Li Y
    J Clin Neuromuscul Dis; 2019 Jun; 20(4):200-206. PubMed ID: 31135623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravenous immunoglobulin and plasmapheresis on nerve conduction parameters compared to the natural course of Guillain-Barré syndrome.
    Kalita J; Mahajan R; Kumar M
    J Clin Neurosci; 2024 Jul; 125():76-82. PubMed ID: 38759351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update.
    Uncini A; Kuwabara S
    Clin Neurophysiol; 2012 Aug; 123(8):1487-95. PubMed ID: 22480600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment related fluctuation and response to intravenous immunoglobulin therapy in post COVID-19 Guillain-Barre syndrome.
    Gupta S; Chandra A; Ray BK; Pandit A
    Diabetes Metab Syndr; 2021; 15(5):102246. PubMed ID: 34416468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthostatic hypotension as a presenting symptom of the Guillain-Barré syndrome.
    Zhang Q; Gu Z; Jiang J; Bai X; Feng Y; Huang Z; Zhou D; Liu L
    Clin Auton Res; 2010 Jun; 20(3):209-10. PubMed ID: 20058051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurophysiology in Guillain-Barré syndrome].
    Kokubun N
    Brain Nerve; 2015 Nov; 67(11):1321-8. PubMed ID: 26560947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome and its variants: a case of acute motor-sensory axonal neuropathy in Jamaica.
    Fletcher-Peddie K; Alfred R; Penn-Brown K; Gayle F; Gilbert DT; Elliot V; Ferguson TS
    West Indian Med J; 2013 Sep; 62(7):658-66. PubMed ID: 24831908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.
    Akçay N; Menentoğlu ME; Bektaş G; Şevketoğlu E
    J Med Virol; 2021 Sep; 93(9):5599-5602. PubMed ID: 33851741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.
    Chakraborty U; Hati A; Chandra A
    Diabetes Metab Syndr; 2021; 15(6):102326. PubMed ID: 34731822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial nerve conduction studies provide insight into the pathophysiology of Guillain-Barré and Fisher syndromes.
    Shahrizaila N; Goh KJ; Kokubun N; Abdullah S; Yuki N
    J Neurol Sci; 2011 Oct; 309(1-2):26-30. PubMed ID: 21849173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody].
    Ogawa G; Kaida K; Shiozaki Y; Araki M; Kimura F; Kamakura K
    Rinsho Shinkeigaku; 2009 Aug; 49(8):488-92. PubMed ID: 19827599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.